Durga A. Gadgil

Translation and Validation of COST - FACIT (Version 2) Questionnaire into Hindi and Marathi to Assess Financial Toxicity in Indian Cancer Patients

Amit Joshi, Devanshi Kalra, Nandini Sharrel Menon, Durga A. Gadgil et autres

Background Cancer is one of the most expensive and exhaustive medical conditions with a huge impact on the financial condition of the patient and their family members. A lot of advancements have led to improvement in the survival of the patients but …

in (code pays fourni par la source)

Building research capacity in India

Durga A. Gadgil, Manju Sengar, C. S. Pramesh, Rajendra Achyut Badwe et autres

Clinical research is an essential part of evidence-based medicine. The conduct of high-quality clinical research requires the backing of strong infrastructure, especially well-trained clinical research professionals. Tata Memorial Centre is the largest public cancer center in India and has been offering a …

in (code pays fourni par la source)

The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research

Priya Ranganathan, Girish Chinnaswamy, Manju Sengar, Durga A. Gadgil et autres

in, ca, be, nz, us, gb, fr, au, ch (code pays fourni par la source)

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

Nalinie Joharatnam‐Hogan, Fay Helen Cafferty, Richard A Hubner, Daniel Swinson et autres

gb, in (code pays fourni par la source)

Effect of a planned training session on good clinical practice knowledge in research professionals: A pilot study

Kasturi Awatagiri, Durga A. Gadgil, Sadhana Kannan, Pallavi Pratisad Rane et autres

CONTEXT: Adherence to good clinical practice (GCP) guidelines by the researcher provides public confidence that the rights, safety and well-being of human participants involved in research are protected. It has been observed that researchers require basic GCP training. Considering this, we had …

in (code pays fourni par la source)

Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in India

Yeshwant Krishna Amdekar, Sanjay Kewalchand Lalwani, Ashish Bavdekar, Sundaram Balasubramanian et autres

BACKGROUND: The childhood burden of disease attributable to Streptococcus pneumoniae is particularly high in India. The immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) were compared with 7-valent pneumococcal conjugate vaccine (PCV7) in a randomized, active-controlled, double-blind trial conducted at 12 …

in, gb, us (code pays fourni par la source)

Comparison of the efficacy of ciclesonide 160 μg QDand budesonide 200 μg BID in adults with persistent asthma: A phase III, randomized, double-dummy, open-label study

Pramod V. Niphadkar, Kannivelu Jagannath, Jyotsna Madanmohan Joshi, Nilkanth Tukaram Awad et autres

in, nl (code pays fourni par la source)

An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. The International Collaborative Study of Severe Anaphylaxis.

Joan‐Ramon Laporte, F. J. de Latorre, Durga A. Gadgil, D.V. Chandrasekhar et autres

To quantify the risk of severe anaphylaxis due to drugs and other exposures in hospital patients, a study of incident cases has been in progress since 1992, with data collection in Hungary, Spain, India, and Sweden. All cases of anaphylaxis that develop …

An Epidemiologic Study of Severe Anaphylactic and Anaphylactoid Reactions among Hospital Patients

Joan‐Ramon Laporte, F. J. de Latorre, Durga A. Gadgil, D.V. Chandrasekhar et autres

To quantify the risk of severe anaphylaxis due to drugs and other exposures in hospital patients, a study of incident cases has been in progress since 1992, with data collection in Hungary, Spain, India, and Sweden. All cases of anaphylaxis that develop …